The Weekly Litigation News Digest is now live. Subscribe now

Lek Pharmaceuticals Dd competitive analysis

Loading summary...

Explore patent oppositions filed by Lek Pharmaceuticals Dd against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Capsule FormulationsCHEMOCENTRYXJun 12, 2025
Capsule FormulationsCHEMOCENTRYXJan 12, 2024
Process For Drying Of Bibw2992, Of Its Salts And Of Solid Pharmaceutical Formulations Comprising This Active IngredientBOEHRINGER INGELHEIMDec 20, 2019
Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICAAug 14, 2019

Explore Lek Pharmaceuticals Dd's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Mar 6, 2019New Process For The Synthesis Of 1-(2-((2,4-Dimethylphenyl)Thio)Phenyl)Piperazine2
Feb 27, 2019A Method For Controlling The Main Complex N-Glycan Structures And The Acidic Variants And Variability In Bioprocesses Producing Recombinant Proteins2
Jan 24, 2018Production Of Glycoproteins With Low N-Glycolylneuraminic Acid (Neu5Gc) Content1

Latest PTAB cases involving Lek Pharmaceuticals Dd

Discover the latest PTAB cases involving Lek Pharmaceuticals Dd, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Lek Pharmaceuticals Dd with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LEK PHARMACEUTICALS DD45 - -
BOEHRINGER INGELHEIM314221
CHEMOCENTRYX - 4 - -
DIPHARMA FRANCIS11 - -